drugset / Trial / NCT00809289
Phase 1 Thorough QT (TQT) Study in Young Healthy Volunteers
RandomizedCrossoverDouble-blindBasic science
Summary
This Phase 1 study will assess the effects of esreboxetine on the heart. In particular the effects on a specific electrocardiogram (ECG) measurement called QTc will be measured.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |
| Subject | [S,S]-Reboxetine | Unknown | 10 mg | — |